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Abstract
Background: Hypoxic–ischemic encephalopathy (HIE) in perinatal condition is highly associated with mortality and several
neurological disabilities. The present experiment was blueprinted to ascertain the protective efficacy of mangiferin (MF) against
hypoxic–ischemic brain injury in neonatal rats.
Materials and Methods: Fourth six neonatal rats (pups) were randomly separated into four groups as a sham group that received only
water (control; n=12), pups exposed to Hypoxic–ischemic (HI) insult (HI group-II; n=11), pups receiving 20 (MF 20+HI-III; n=11) or 40
(MF 40+HI-IV; n=12) mg/kg b. wt of MF dissolved in water via i.p. for 7 consecutive days as pretreatment regimen before HI insult as
well as one-time post treatment after HI insult.
Results: MF pretreatment for seven days considerably attenuated the cerebral infarct size, edema level, lipid peroxidation (MDA),
inflammatory markers (TNF-α, IL-1β, IL-6, and NF-p65 subunit) as well as greatly ameliorated the antioxidant activities of catalase 
(CAT), superoxide dismutase (SOD), and glutathione reductase (GSH) and thereby maintaining the redox balance. The number of viable
neuronal count (nissl bodies) was exponentially increased on administration with both the dosages of MF. Both the dosages showed
substantial protection against HIE, however, 40 mg of MF exhibit superior neuroprotection in equivalence with 20 mg of MF.
Conclusion: The results of the present study distinctly proving the beneficial effect of MF against HIE by concomitantly improving
neuronal count and antioxidant status. Hence, we recommend MF might be used for treating neonatal HIE with some standard drugs.
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Introduction
Hypoxic-ischemic encephalopathy (HIE) is the condition that highly affects newborn infants after perinatal asphyxia and
results in numerous neurological disorders. Statistical data indicated that 55-60% of infants with inborn HIE might suffer from severe
disabilities such as epilepsy, mental retardation, cerebral palsy or even die (Kurinczuk et al., 2010; Long & Brandon, 2007). The etiology
for HIE are associated with lack of oxygen supply to the brain by interrupting blood flow and finally leads to various metabolic
derangements like an energy failure, excitotoxicity, oxidative stress (lipid peroxidation), inflammation, delayed cell death due to
alteration in calcium homeostasis (Panickar & Anderson, 2011; Lai & Yang, 2010). Even though some treatment regimen are available
for cerebral ischemia (HIE) such as anticonvulsants (antiepileptic), hypothermic treatments, and stem cell transplant, but none of them
showed better results against HIE (Sun et al., 2015). Ample evidence inferred that impaired antioxidant with elevated free radicals
(oxidative stress), and the neuroinflammatory response is considered to be the major reason for HIE (Sadeghnia et al., 2012; Slemmer at
al., 2008). Therefore, a plant drug that might specifically lower the oxidative stress and inflammation with anti-apoptotic effect probably
lowers the rate of HIE in the neonatal model. Moreover, several studies had proven that polyphenols might show some beneficial effect
against HIE due to their antioxidant and anti-inflammatory properties (West et al., 2007; Rong et al., 2013).
Mangiferin (MF) is a C-glucosyl-xanthone (polyphenol) which are commonly found in the fruits, bark, leaves of Mangifera
indica L. (Anacardiaceae family) and other plants. MF has unique structural features due to binding of glucose moiety with condensed
aromatic ring, which make its higher bioavailability (Mirza et al., 2013). Mangifera indica which are often used in traditional medicine
for its numerous biological properties (Garrido-Suárez et al., 2014) exhibit a wide array of pharmacological activities like antioxidant,
anti-inflammatory, anti-apoptotic, antimicrobial, immunomodulatory, memory enhancer, gastroprotective and neuroprotective properties
(Carvalho et al., 2007; Campos-Esparza et al., 2009; Márquez et al., 2010). Moreover, MF possesses the iron-complexing capacity and
thus suppresses free radical generation and concomitantly lowers the neuronal lipid peroxidation (Pardo-Andreu et al., 2005). MF has
been reported to decrease Ca2+ overload and thereby alleviate glutamate excitotoxicity. Furthermore, MF can readily cross the blood-
brain barrier (BBB) to reach the brain to exert its pharmacological activities (Amazzal et al., 2007). Moreover, the neuroprotective effect
of MF in rats pups against hypoxic–ischemic brain injury (HIBI) or HIE were yet to prove. Owing to its diverse biological activities of
MF, it would be worth to elucidate whether MF exerts neuroprotection against HIE by assessing cerebral infarct area, edema as well as
various oxidative stress and inflammatory markers in neonatal rats.
Materials and Methods
Chemicals
MF (1, 3, 6, 7-Tetrahydroxyxanthone C2-β-D-glucoside), 2, 3, 5-tritriphenyl-tetrazolium chloride, glutathione were purchased  
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from Sigma-Aldrich (St. Louis, MO, USA). Pyrogallol, sodium citrate, potassium dichromate, heparin, Tris HCL, formaldehyde,
isopropanol, chloroform, pentobarbital sodium was supplied by Lingjin Co. Ltd, Shanghai, China. All the other chemicals used in the
current study were of analytical grade.
Experimental Animals
Seven days old (P7) Sprague-Dawley (SD) rat pups are weighing 14-18 g of either sex, were procured from animal house of
Central Hospital Zhumadian City, China. Pups were maintained at constant room temperature (35-37 °C) and had free access to food and
water (ad libitum). The ethical committee of Zhumadian Central Hospital (CPCSEA24/2015), approved the experiment, which were
according to guidelines from the National Institutes of Health Guide for the Care and Use of Laboratory Animals to minimize the animal
suffering.
Procedure for HI Insult and Treatment Regimen
Induction of hypoxia-ischemia was carried out as proposed previously by Vannucci et al. (1998) with mild changes. Fourteen
days old neonatal SD (P14) rats were anesthetized with 3% isoflurane and maintained by 1.5%. The incision was made in the midline
near the neck to isolate the unilateral common carotid artery were dissected and ligated by silk surgical suture and returned to respective
dams. After 2 h of the recovery period, pups were transferred from dams to hypoxia chamber that were maintained at 37 °C with the
assistance of water bath and exposed to 8% O2 & 92% N2 by an oximeter (Pro OX Controller, Biospherix, NY, USA) for 2 h. After the
hypoxic induction, all pups were taken back to their respective dams and immediately water or MF dissolved in water was administered
intraperitoneally (i.p.) in HI or MF group as one-time post treatment. Based on a preliminary dose-dependent study in HI model (data not
shown), the doses of 20 and 40 mg/kg of MF were chosen for the present study and administered i.p. for 7 days before induction of HI. In
sham control pups, the carotid artery was not ligated and was exposed to the normoxic condition (21% O2).
Fifty-two rats were utilized for the present study out of which six rats were either dead during HI induction or not active and
thus, only forty-six pups were completely involved. Those neonatal pups were divided into four groups as a sham group (control; n=12),
which received only water, pups subjected to HI insult (HI group-II; n=11), pups receiving 20 mg/kg b. wt of MF dissolved in water via
i.p. (MF 20+HI-III; n=11), pups receiving 40 mg/kg b. wt of MF dissolved in water via i.p. (MF 40+HI-IV; n=12) for 7 days before HI
insult (pretreatment). During induction, the time interval was properly maintained to nullify the statistical errors. All the pups were
euthanized on the 16th day (P16) by injecting (i.p.) with pentobarbital sodium and brains were removed immediately. Each group was
again subdivided into two groups, of which one sub-group brains were fixed in 4% paraformaldehyde for morphological studies (nissl
staining) and other sub-group brains for separating cerebral cortex and then homogenized (pooled) by using lysis buffer and used for
biochemical analysis.
Morphological Analysis
Infarct Area
The 2, 3, 5-triphenyl-tetrazolium chloride (TTC) staining method was employed to measure the cerebral infarct area as reported
elsewhere (Li et al., 2012). In brief, brain was sectioned into four pieces (1 mm) and stained with 0.1% solution of TTC at 37°C for 7 min
and rinsed with phosphate buffered saline (PBS) and fixed with 10% formaldehyde. The infarct area was determined using an image
analyzing system (ImageJ, Bethesda, MD, USA) and the values are expressed in percentage. Infarct area was determined using the
formula,
Infarct area = (total infarct area/whole brain section area) X 100%.
Cerebral Edema
The cerebral edema was analyzed using previously reported method with a few changes (Mdzinarishvili et al., 2007). To
evaluate the cerebral edema initially, the wet and dry weight of brain samples was weighed. Cerebral edema was calculated using the
formula:
The cerebral edema = (wet weight _ dry weight)/wet weight X 100%.
Cresyl Violet Staining (Nissl)
The fixed brain samples were sectioned (4 µm) and those sections were hydrated with 1% toluidine blue at 40 °C for 15 min,
followed by hydration using double distilled water and dehydrated. The sections were embedded in paraffin and finally staining with
cresyl violet. The images of nissl stained cortex are picturized by the computerized imaging system (Imaging-Pro-Plus software; Media
Cybernetics, Inc, MD, USA) to analyze nissl bodies (viable neuron).
Biochemical Analysis
Oxidative Indexes
The activities of various antioxidant enzymes like superoxide dismutase (SOD), catalase (CAT) and reduced glutathione (GSH)
as well as the levels of lipid peroxidation product - malondialdehyde (MDA) were assayed and measured by using commercial kit
method based on the manufacturer's protocol (Nanjing Jiancheng Bioengineering Institute, Nanjing, China), respectively. The Bradford
method was employed to assess the protein concentration.
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Assay of Inflammatory Markers
The proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 in cerebral homogenate were assessed by commercially  
available ELISA kits (sandwich enzyme immunoassay) based on the manufacturer's instructions (Thermo Fisher Scientific Inc, MA,
USA). Similarly, the concentration of the NF-κb free p65 subunit in the nuclear fraction (Cell Biolabs Nuclear/Cytosolic Fractionation 
Kit) of the cerebral cortex were determined by ActivELISA (Imgenex, San Diego, USA) kit.
Statistical Analysis
The values were explicated as mean ± standard deviation (SD). The changes between control and experimental rats were
determined by one-way analysis of variance (ANOVA) followed by Tukeys test using the SPSS 21 version (SPSS Inc., Chicago, USA).
A p-value less than 0.05 was denoted as statistically significant.
Results
Impact of MF on Cerebral Infarct Area
The cerebral infarct area in the rat brain was detected by staining with TTC (Fig. 1). To manifest the neuroprotective effect of
MF against HIE, we measured the infarct size in experimental and control neonatal pups. The sham stained section displayed a uniform
stained region, thus indicating that blood flow was not interrupted. The cerebral infarct area of rats in the HI group was 29.45 ± 2.64%,
which is highly significant as compared with the sham control group. Thus, indicating the deleterious events of HI by showing the
unstained area as white patches. The cerebral infarct area of both treated MF group (20 and 40 mg/kg) were 19.32 ± 2.05 and 14.79 ±
2.10 respectively, thus effectively ameliorated hypoxia-induced brain damage by displaying less unstained area with the predominantly
stained area.
Figure 1: Effects of MF on the cerebral infarct area in sham control and experimental neonatal rats. The pictorial representation of
coronal section stained with TTC (1A), showed normal sham control (n=12) with a uniform stained region, whereas HI group (n=11)
coronal section portrait few unstained area (white patches) which indicates the ischemic area. However, on treatment with both dosages
of MF (n=11; 12) showed less unstained area with the predominantly stained area. The area of cerebral infarct was expressed in
percentage (1B). Statistical significance (p value): **p<0.01, *p<0.05 (a) compared with the control group, (b) compared with the HI-
induced group.
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Impact of MF on Cerebral Edema
The cerebral edema was evaluated based on the wet and dry weight of sham control and experimental pups, which are
illustrated in Fig 2. There were no edematic changes in sham control rats. In the case of HI insult group (85.01%) a substantial escalation
was noted on equivalence with the sham group (control). MF (20 and 40 mg/kg) injected groups exhibit the cerebral edema as 71.22%
and 63.87%, respectively, thus proving its neuroprotective potential by lowering the edema (water) levels significantly vs. HI group.
Figure 2: Effects of MF on cerebral edema in sham control (n=12) and experimental neonatal rats (n=12).
Statistical significance (p value): **p<0.01, *p<0.05 (a) compared with the control group, (b) compared with the HI-induced group.
Impact of MF on the Cerebral Section with Nissl Staining
Figure 3 portraits the histopathological changes in a cerebral section of pups in sham control, and experimental neonatal rats.
Transection of sham control (n=12) depicts the normal structure with several prominent nissl bodies (3A). Pronounced alterations in
neuronal morphology were observed in HI-induced rats (n=11) with pyknotic neurons, interstitial edema and less visible nissl bodies
(3B). However, on pretreatment with both doses of MF (n=11; 12) concomitantly improved the number of nissl bodies (3C and D) on
equivalence with HI group (data not shown), which indicates its neuroprotective potential.
Figure 3: Effect of MF on the cerebral section with nissl staining in sham control and experimental neonatal rats. Transection (400 x) of
the sham control portrait normal structure with several prominent nissl bodies (3A). Enormous changes in neuronal morphology were
noticed in HI-induced rats with pyknotic neurons and few visible nissl bodies (3B). However, upon supplementation with both doses of
MF concomitantly improved the number of nissl bodies (3C and D). Scale bar- 50 µm
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Impact of MF on Oxidative Indexes like LPO and Antioxidants
Table 1 represents the effect of MF pretreatment on the levels of lipid peroxidative products like Malondialdehyde (MDA) and
antioxidants in control and experimental neonatal rats. To assess whether MF pretreatment can lower the brain oxidative stress, by
elevating the antioxidant levels as well as lower the lipid peroxidative products (MDA) in HI-induced neonatal pups. The cerebral MDA
level was considerably raised (p < 0.01) in hypoxia group. In the case of antioxidant activities of SOD, CAT, and GSH were substantially
suppressed in the HI group (p < 0.01) on equivalence with the control group. Compared with HI group, MF injected (20 and 40 mg/kg)
pups exhibit a marked decline (p < 0.05) in the levels of LPO as well as showed an exponential increase in the activities of SOD, CAT,
and GSH.
Table 1: Effect of MF on the activities of brain antioxidants and lipid peroxidation in sham control and experimental neonatal rats
Values were expressed as mean ± S.D for 11 or 12 rats in each group.
Statistical significance (p value): **p<0.01, *p<0.05 (a) compared with the sham control group, (b) compared with the HI injured group.
One unit (U) of SOD activity was defined as the amount of enzyme required for 1 mg tissue proteins in 1 ml of a reaction mixture SOD
inhibition rates to 50% as monitored at 550 nm.
One unit (U) of CAT activity was defined as 1 mg tissue proteins consumed 1 μmol H2O2 at 405 nm for 1 second.
Impact of MF on the Concentration of Inflammatory Markers
The anti-inflammatory effect of MF evaluated against HI induction were addressed by determining the concentrations of
various pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and nuclear factor NF-p65 subunit of NF-κB (Table 2). A considerable 
elevation (p<0.01) in the concentration of those inflammatory markers in brain tissue of HI-induced rats was observed on equating with
sham control rats. HI-induced pups treated with MF (20 and 40) dramatically (p < 0.01) diminished the concentrations of these pro-
inflammatory cytokines, thus proving its anti-inflammatory efficacy.
Discussion
Although, the number of studies indicated the neuroprotective potential of MF in various models (Lemus-Molina et al., 2009;
Kasbe et al., 2015), till date, none had proved the protective effect of MF against HIE condition in neonatal rats. Hence, we sought to
assess the protective efficacy of MF against HIE by evaluating the cerebral infarct size, edema, lipid peroxidation (MDA), antioxidant
status and inflammatory markers in neonatal pups. Typically, the neuronal damage during ischemic condition is evaluated by assessing
the area/size of brain infarction by TTC staining method (Yousuf et al., 2009). The fundamental principle of the TTC staining technique
is based on the activation of mitochondrial cytochrome oxidase enzyme in the viable (neuronal) cells to produce a red color. In the case
of dead cells, this TTC stain will not react and hence the cell (tissue) appears white. The outcome of TTC staining of sham control
cerebral section showed uniform stained region, whereas HI group coronal section portrait few unstained areas (white patches) which
indicate the ischemic area. However, on treatment with both, dosages of MF showed less unstained areas with a predominantly stained
area that clearly depict the neuroprotective nature of MF by elevating the presence of viable that are affiliated with rich red color stain
than HI insulted pups. Similarly, Prabhu and his colleagues (2012) inferred that treatment with MF significantly reduced the infarct area
in a rat model.
Group
LPO (nmols/mg
protein) SOD(U/mg
protein)
CAT
(U/mg
protein)
GSH
(µg/mg protein)
Sham control 0.32±0.04 3.52±0.42 67.67±7.25 7.98±0.89
HI 0.85±0.09 a** 2.63±0.26 a** 51.20±4.74 a** 6.05±0.51 a**
MF 20 + HI 0.67±0.08 b** 3.06±0.18 b* 57.56±6.03 b* 6.81±0.40 b*
MF 40 + HI 0.44±0.06 b** 3.36±0.26 b** 62.23±5.34 b** 7.59±0.90 b**
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Table 2: Effect of MF on the activities of inflammatory markers in sham control and experimental neonatal rats
Values were expressed as mean ± S.D for 11 or 12 rats in each group.
Statistical significance (p value): **p<0.01, *p<0.05 (a) compared with the sham control group, (b) compared with the HI injured group.
Cerebral edema is a major complication related to hypoxic-ischemia, as edema might elevate intracranial pressure with enlargement of
brain tissue, which finally leads to cell death (Panickar & Anderson, 2011). It has been hypothesized that during HI condition, the blood
flow was interrupted and contribute to an electrolytic imbalance that leads to increased movement of water (increases Aquaporin 4
expression) by altering BBB integrity and thus leads to edema (Wang et al., 2013). To validate the above statement, we found a marked
increase in edema level (water content) in HI insult group on equivalence with the sham control group. The cerebral edema levels in MF
injected group were substantially reduced, thus proving its neuroprotective potential owing to attenuating oxidative stress and thus
ameliorated BBB integrity. Our results are well supported by Tan and his coworkers (2011), also pointed out that MF can effectively
reduce the cerebral infarct size in a cerebral ischemic rat model by improving the antioxidant status and thus preserving the integrity of
BBB.
The degree of ischemic neuronal injury was determined by checking the number of normal motor neurons using cresyl violet
staining procedure based on the presence of nissl bodies (Telles et al., 2014). Enormous changes in neuronal morphology were noticed in
a hypoxic-ischemic group with pyknotic neurons as well as few visible nissl bodies, thus indicating the neurotoxicity in HI insult
condition with reduced viable neuronal cells. Nevertheless, upon administration with MF concomitantly ameliorated the number of
visible nissl bodies (data not included), thus confirm its neuroprotective nature of MF. Previously, Mangifera extract is reported to
attenuate ischemia-induced neuronal loss by improving neuronal count, which were evidenced by cresyl violet stained brain section
(Sánchez et al., 2001).
Epidemiological studies showed the direct relationship between oxidative stress and HIE. Therefore, we checked the
antioxidant status by assessing the activities of enzymic antioxidants like SOD, CAT, GPx as well as oxidative stress marker-Lipid
peroxidation products like MDA. A growing body of evidence has demonstrated that neonatal brain tissues are highly susceptible to free
radical damage (oxidative stress) because of increased oxygen consumption, lower endogenous antioxidant levels as well as increased
lipid content which eventually results in neuronal and glial cells damage (Sadeghnia et al., 2012; Fukui et al., 2002). The enzymic
antioxidant activities like SOD, CAT, and GSH were substantially suppressed in HI insulted pups due to elevated oxidative stress. MF
(20 and 40 mg/kg) pretreatment for 7 days exhibits an exponential increase in the activities of SOD, CAT, and GSH by activating
transcription factor NF-E2-related factor-2 (Nrf2) a key regulator of endogenous anti-oxidant and thus preserving BBB function. We also
checked the mRNA expression of Nrf2, where the expression is markedly upregulated upon treatment with MF (data not presented).
Several experimental models had shown that MF would act as a protective agent by alleviating oxidative stress by upregulating Nrf2
related genes and thus improved the overall antioxidant status (Mahmoud-Awny et al., 2015; Sethiya, & Mishra, 2014). Also, MF was
shown to increase endogenous antioxidants such as SOD, CAT and glutathione in rat and cell line models (Rajendran et al., 2008;
Amazzal et al., 2007).
Meanwhile, the cerebral lipid peroxidation product like MDA level was significantly increased in hypoxia group, owing to
increased free radical generation that damaged the fatty acids and phospholipids present in the cell membrane and results in increased
neuronal damage. Lipid peroxidation is the major contributor for decreased neuronal count, which we found during morphological
analysis (nissl stain). Seven days pretreatment successfully protected the neuronal cells by increased endogenous antioxidant system and
thus the levels of MDA were significantly reduced. A review from Mirza et al., 2013, also indicated that the antioxidant activity of MF is
majorly contributed by catechol moiety (iron complexing capacity), which inhibit the production of free radicals by inhibiting the
conversion of Fe2+ to Fe3+ complex and that would be the reason for maintaining the redox balance by elevating antioxidant status in MF
treated pups. Supplementation of MF for 7 days probably eases oxidative stress and lipid peroxidation as well as protects BBB in
schizophrenia mice model (Rao et al., 2012).
Group
TNF-α
(ng/mg
protein)
IL-1β 
(ng/mg
protein)
IL-6
(pg/mg
protein)
NF-p65
(pg/mg
protein)
Sham control 110.34±11.93 62.73±4.08 75.23±9.01 81.27±4.51
HI 298.28±21.37 a** 172.90±14.46 a** 255.38±22.82 a** 197.72±17.34 a**
MF 20 + HI 214.34±15.82 b** 121.64±16.06 b* 174.19±16.92 b* 134.92±12.48 b**
MF 40 + HI 152.45±19.94 b** 88.11±10.03 b** 101.46±11.53 b** 99.42±11.66 b**
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Existing evidence suggest that impaired antioxidant with elevated free radicals (oxidative stress) and the neuroinflammatory
response is considered to be the major reason for HIE (Sadeghnia et al., 2012; Slemmer at al., 2008). Both the events (oxidative stress
and inflammation) are interconnected with one another. It is well documented that TNF-α triggered by oxidative stress during HIE is the 
critical process, which initiate NF-κB transcription factor (specifically nuclear factor NF-p65), which upregulate the upstream genes 
related to pro-inflammatory cytokines like IL-1β, IL-6, TNF-α (Li et al., 2013; Block et al., 2007). Even our ELISA test also ensured that 
the levels of all pro-inflammatory markers and nuclear factor NF-p65 were significantly elevated. Administration of MF for 7 days
concomitantly lower those inflammatory markers by inactivating NF-κB transcription factor as well as mitigating oxidative stress. Our 
results are corroborated by the results of Kasbe and his coworkers (2015), they also pointed out that MF 20 and 40 mg/kg showed anti-
inflammatory activity by lowering the production of various pro-inflammatory cytokines in brain tissue of aluminum-induced
neurotoxicity. Few animal studies had pointed out that MF probably inhibits TNF-α induced IκB degradation and thus subdue the 
translocation of NF-kB to DNA (activation), thereby preventing the transcription of genes involved in the production of several pro-
inflammatory cytokines (Garrido-Suárez et al., 2010). Moreover, Márquez and his coworkers, (2012) also proved that MF can effectively
suppress inflammatory response by inhibiting the activation of microglial cells and neutrophil infiltration and thus negatively regulate the
expression if NF-κB and subsequent pro-inflammatory cytokines.   
We had some limitation in our studies as we checked the neuroprotective effect in neonatal rats for only 7 days (chronic study)
but long term effect is yet to be explored. Also, we do not include some apoptotic parameters to check the anti-apoptotic effect pertained
to neuroprotective effect of MF. However, in future, we are planning to continue our work by checking the impact of MF by assessing
staining, BBB integrity, expression of HIF-1α, endothelial factors as well as a behavioral test to explore the detailed mechanism behind 
the neurotherapeutic effect of MF in neonatal rats.
Conclusion
Taking together, MF showed a neuroprotective effect against HIE induced neonatal rats by decreasing cerebral infarct size,
edema as well as various oxidative stress and inflammatory markers. Also, it improved the viable neuronal count by increasing the
activities of antioxidant enzymes. Both the dosages (20 and 40 mg/kg b. wt) showed substantial protection against HIE, however, 40 mg
of MF exhibit superior neuroprotection in equivalence with 20 mg of MF. Therefore, MF might be used for treating neonatal HIE with
some standard drugs or standard treatment procedure. Also, in future, the precise mechanism underlying the neuroprotective effect of MF
has to be explored.
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